THOMAS BRAXTON KING - 04 Sep 2025 Form 4 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Role
Director
Signature
/s/ Sandra Thomson as attorney-in-fact for Thomas B. King
Issuer symbol
ACHV
Transactions as of
04 Sep 2025
Net transactions value
-$387,407
Form type
4
Filing time
08 Sep 2025, 16:54:43 UTC
Previous filing
10 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KING THOMAS BRAXTON Director 22722 29TH DR SE, SUITE 100, BOTHELL /s/ Sandra Thomson as attorney-in-fact for Thomas B. King 08 Sep 2025 0001279309

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACHV Common Stock Options Exercise $0 +455,000 $0.000000 455,000 04 Sep 2025 Direct F1
transaction ACHV Common Stock Sale $387,407 -139,858 -31% $2.77 315,142 04 Sep 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACHV Performance Restricted Stock Unit (PRSU) Options Exercise $0 -455,000 -100% $0.000000 0 04 Sep 2025 Common Stock 455,000 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
F2 Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Represents PRSUs previously reported on January 14, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
F5 Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F6 Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.